Paper · 17401366
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
Gudmundsson J and 50 others. Nat Genet, 2007. Cited by 669 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Papers, record 17401366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17401366
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromosomes, Human, Pair 8 | Major topic |
| Genetic Linkage | Major topic |
| Genetic Predisposition to Disease | Major topic |
| Genetic Variation | Major topic |
| Prostatic Neoplasms | Major topic |
| Black or African American | |
| Europe | |
| Genomics | |
| Haplotypes | |
| Humans | |
| Male | |
| Polymorphism, Single Nucleotide | |
| United States | |
| White People |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01590472 | Do Your Genes Put You at a Higher Risk of Developing Mesothelioma | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17,460,686 | Multiple prostate cancer risk variants on 8q24. | https://conductscience.org/library/papers/17460686 |
Source PubMed
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by456
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 669 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,415,294 | Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population-Based Study. | Cancer Med | 2026 | https://conductscience.org/library/papers/42415294 | PubMed |
| 41,681,959 | SLPI in Prostate Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681959 | PubMed |
| 41,468,516 | Decoding the germline genetic architecture of prostate cancer at a single cell resolution. | PLoS Genet | 2025 | https://conductscience.org/library/papers/41468516 | PubMed |
| 41,062,477 | Combined SNPs sequencing and allele specific proteomics capture reveal functional causality underpinning the 2p25 prostate cancer susceptibility locus. | Nat Commun | 2025 | https://conductscience.org/library/papers/41062477 | PubMed |
| 41,024,066 | Decoding ancestry-specific genetic risk: interpretable deep feature selection reveals prostate cancer SNP disparities in diverse populations. | BioData Min | 2025 | https://conductscience.org/library/papers/41024066 | PubMed |
| 40,656,960 | Associations between squalene epoxidase gene polymorphisms and obesity. | PeerJ | 2025 | https://conductscience.org/library/papers/40656960 | PubMed |
| 40,180,576 | Shared requirement for MYC upstream super-enhancer region in tissue regeneration and cancer. | Life Sci Alliance | 2025 | https://conductscience.org/library/papers/40180576 | PubMed |
| 39,780,503 | Introduction to androgenetics: terminology, approaches, and impactful studies across 60 years. | Andrology | 2025 | https://conductscience.org/library/papers/39780503 | PubMed |
| 39,766,883 | Swedish Genome-Wide Haplotype Association Analysis Suggests Breast Cancer Loci with Varying Risk-Modifying Effects. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39766883 | PubMed |
| 38,980,713 | Research Trends and Evolution in Radiogenomics (2005-2023): Bibliometric Analysis. | Interact J Med Res | 2024 | https://conductscience.org/library/papers/38980713 | PubMed |
1 to 10 of 456
See all 456 cited byGenes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASC8 | 727,677 | PubTator's text mining | https://conductscience.org/library/genes/727677 | NCBI Gene |
| HPC10 | 100,188,834 | PubTator's text mining | https://conductscience.org/library/genes/100188834 | NCBI Gene |
| LRATD2 | 157,638 | PubTator's text mining | https://conductscience.org/library/genes/157638 | NCBI Gene |
| MYC | 4,609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| POU5F1B | 5,462 | PubTator's text mining | https://conductscience.org/library/genes/5462 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17401366
GET https://conductscience.org/api/papers/v1/17401366/authors?page=2